E. Skogvoll et al., Helicopter emergency medical service in out-of-hospital cardiac arrest - a10-year population-based study, ACT ANAE SC, 44(8), 2000, pp. 972-979
Citations number
25
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Background: In 1988, Norway established a countrywide, physician staffed he
licopter emergency medical service (HEMS). The medical benefit remains cont
roversial. The aim of this study was to estimate the population incidence o
f HEMS involvement in out-of-hospital cardiac arrest, report the patient ou
tcome and evaluate the contribution of HEMS to survival.
Methods: We studied HEMS operations in central Norway (population 364 000)
during a 10-year period (1988-1997). Missions were classified according to
type and quality of intervention done by the primary care providers. HEMS w
itnessed cardiac arrests were not considered. Patient outcome was determine
d as survival to hospital discharge with cerebral performance category (CPC
) score. The contribution made by HEMS in each survivor was assessed from t
he timing of return of spontaneous circulation (ROSC) and from subsequent n
eed for advanced medical intervention. The relation between survival and HE
MS response time was investigated by ordinal correlation.
Results: A total of 541 requests (14.9 per 100 000 inhabitants per year) we
re identified, of which 424 missions were completed. population survival in
cidence of 1 per 100 000 per year. Ninety-five percent of survivors made a
favourable cerebral outcome (CPC 1 or 2). General practitioners/ambulance p
ersonnel resuscitated 29 out of 36 survivors. The remainder achieved ROSC a
fter HEMS arrival. Case by case, HEMS assistance was considered possibly im
portant in 17 survivors. We found no relation between survival and HEMS res
ponse time (P=0.77).
Discussion: Survival following out-of-hospital cardiac arrest assisted by H
EMS in this region is low, but not negligible. While primary care is most i
mportant, HEMS may possibly contribute to the additional survival of 0.19 t
o 0.46 patients per 100 000 per year. This benefit appears to be independen
t of HEMS response time.